FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats

Brain Research

Volumn 906, Issue 1-2, 2001, Pages 184-189

  Tanaka, Ken ichi ^a,b   Hori, Koji ^b,c   Wada Tanaka, Naoko ^c   Nomura, Masahiko ^c   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b RIKKYO UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Demyelination; Discrimination learning; Immunophilin ligand; Neuronal cell death; White matter ischemia

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DISCRIMINATION LEARNING; DRUG EFFECT; FRONTAL CORTEX; LEARNING DISORDER; MALE; NERVE CELL LESION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; WHITE MATTER;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; CORPUS CALLOSUM; DEMENTIA, VASCULAR; FRONTAL LOBE; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOSUPPRESSIVE AGENTS; LEARNING DISORDERS; MALE; NEOSTRIATUM; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TACROLIMUS;

EID: 0035816378     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02537-9     Document Type: Article

References (51)

1. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A
2. Peptidyl-prolyl-cis/trans-isomerase activity may be necessary for memory formation
3. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment
4. Inhibition by FK506 of formyl peptide-induced neurotrophil activation and associated protein synthesis
5. Mechanism of NO neurotoxicity
6. The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy
7. The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin
8. Inhibition by FK506 of formyl peptide-induced neurotrophil activation and associated protein synthesis
9. Neuroimmunophilin ligands: Evaluation of their therapeutic potential for the treatment of neurological disorders
10. Dementia in the aged
11. Some problems in giving notice of the name of a disease: With special reference to Alzheimer's disease and vascular dementia
12. A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin
13. Measurement of tissue blood volume in a model system and in the canine intestine by dynamic light scattering
14. Biochemical and molecular characteristics of the brain with developing cerebral infarction
15. Evidence that FK506 alleviates ischemia/reperfusion injury to the rat liver: In vivo demonstration for suppression of TNF-a production in response to endotoxemia
16. Effects of an immunosuppressant, FK506, on interleukin 1alpha production by human macrophages and a macrophage-like cell line, U937
17. Catecholamines in experimental brain ischemia
18. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
19. Oxidative stress in brain ischemia
20. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia
21. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis
22. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression
23. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat
24. Chronic cerebral hypoperfusion-induced neuropathological changes in rats
25. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat
26. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia
27. How does cerebrovascular disease cause dementia
28. Vascular dementia: Diagnostic criteria for research studies
29. Caspases as treatment targets in stroke and neurodegenerative disease
30. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia
31. Neural actions of immunophilin ligands
32. Neurotrophic actions of non-immunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
33. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models
34. Inflammation and glial responses in ischemic brain lesions
35. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporin
36. 2-induced apoptotic cell death by increasing glutathione levels in Neuro 2A neuroblastoma cells
37. Calcineurin inhibitor, FK506, prevents reduction in the binding capacity of cyclic AMP-dependent protein kinase in ischemic gerbil brain
38. Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion
39. Chronic cerebral hypoperfusion disrupts discriminative behavior in acquired-learning rats
40. Chronic cerebral hypoperfusion induces transient reversible monoaminegic changes in the rat brain
41. Oxidative metabolism, apoptosis and perinatal brain injury
42. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
43. White matter lesions after occlusion of the bilateral carotid arteries in the rat: Temporal profile of cerebral blood flow (CBF), oligodendroglia and myelin
44. An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex
45. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats
46. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis
47. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: An immunohistochemical study
48. Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion
49. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral hypoperfusion
50. The impairment of long-term memory formation by the phosphatase inhibitor okadaic acid